ClinicalTrials.gg
CompletedNCT03849014Updated Apr 27, 2021

Comparison of Biochemical Changes in Patients With Trochanteric Region Fracture Fixation With DHS Versus PFN

An interventional study of Dynamic Hip Screw and Proximal Femoral Nail in Hip Fractures, sponsored by Kushtrim Grezda. Completed at 1 site in Kosovo. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2021-04-27.

Sponsored by Kushtrim Grezda · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

Hip fractures are one of the most frequent fractures in older adults. There is still controversy which surgical strategy is the best option for treatment of hip fractures especially trochanteric region fractures. Surgical intervention that follows hip fracture induces biochemical, physiological and fibrinolytic changes that are so-called "second hit phenomenon" which trigger systemic inflammatory response syndrome. The investigators are aiming to study this phenomenon after two different surgical procedures and help surgeons in everyday practice to choose the most suitable surgical treatment for patients with trochanteric region fracture and give the scientific community more evidence which methods is better since there is still controversy.

02

Conditions studied

  • Hip Fractures

Browse trials for

Keywords

  • Hip fractures
  • Inflammatory response
  • Interleukin-6
  • Comparative study
03

In context

Hip Fractures

842 studies on the registry are indexed under Hip Fractures; 165 are open to participants now.

This study's enrollment of 60 is below the median of 86 across 533 interventional studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

This is the only study on the registry with Kushtrim Grezda as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with trochanteric region fractures AO/OTA 31.A1-31.A2
  • Time from fracture till surgery up to 1 week
  • Classification (ASA) I-III
  • Willing to participate

Exclusion criteria

Exclusion Criteria:

  • Polytrauma patients
  • Open fractures
  • Existing local or systemic infection
  • Pre-existing coagulatory disorder
  • Existing
  • use
  • Systemic inflammatory disease
  • Voluntary withdraws of the patient
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Dynamic Hip Screw

    Dynamic Hip Screw is used for internal fixation of fractures of the certain types of hip fractures. The implant assembly consisting of a lag screw, a side plate, and cortical screws that fix the side plate to the proximal femoral shaft.

    Procedure: Dynamic Hip Screw

  • Active comparator
    Proximal Femoral Nail

    The Proximal Femoral Nail offers osteosynthesis for the several types of hip fractures. It consists of an anatomically curved nail, double neck screw, and two locking screws for distal end.

    Procedure: Proximal Femoral Nail

Interventions

  • ProcedureDynamic Hip Screw

    Dynamic Hip Screw fixation: Fracture will be reduced under image intensifier. The incision will be made 7-10 cm with a lateral approach. The fascia lata will be incised and the vastus lateralis muscle will be splited along the axis of the femur, without stripping the periosteum. A135° angle guide will be inserted in the lower half of the femoral neck. The barrel of the plate will be guided to the hip screw by direct palpation to minimize the soft-tissue injury. After the insertion of the cortical screw, soft tissue will be protected with 4.5mm drill sleeve during drilling and tapping.

  • ProcedureProximal Femoral Nail

    Proximal Femoral Nail fixation: Fracture will be reduced under image intensifier. The incision 2-3 cm with a lateral approach that extended from the cranial part to the tip of the greater trochanter. After palpating the greater trochanter tip, the nail will be then introduced manually into the femoral shaft. The guide wire of the anti-rotational hip blade then introduced. The hip blade should be introduced in the direction of the lower half of the femoral neck. Drilling will be performed under soft-tissue protection with a retractor. The blade will be inserted, and a distal static locking screw and end cap will be inserted under soft tissue protection with a drill sleeve.

06

What researchers measure

Primary outcomes

  1. The difference of the level of IL-6 in operated patients.

    The blood will be collected and after that centrifuged and then stored in -20 grade celsius. The analysis of each sample will be performed no later than 3 months.

    Time frame: 1 hour before and 24 hours after operation

Secondary outcomes

  1. The difference of the level of CRP in operated patients.

    The analysis will be performed immediately after the blood sample is collected.

    Time frame: 1 hour before and 24 hours after operation. Length of operation, length of incision, blood loss perioperatively. Complication and mortality rate within 1 month after OP

  2. The difference of the level of D-dimer

    The analysis will be performed immediately after the blood sample is collected.

    Time frame: 1 hour before and 24 hours after operation

  3. The difference of the level of ESR

    The analysis will be performed immediately after the blood sample is collected.

    Time frame: 1 hour before and 24 hours after operation

  4. The difference of the length of operation

    The stopwatch will be turned on from the incision until the end of the skin suture

    Time frame: Intra-operatively

  5. The difference of the level of length of incision

    The measure will be made with centimeters (cm)

    Time frame: After the wound closure

  6. Blood loss

    HB-balance method will be used

    Time frame: Levels of HB before and after surgery. Also the total volume of blood transfusion.

  7. Complications after surgery

    All complications that might occur after surgery will be registered

    Time frame: Within 1 month after surgery

  8. Mortality rate

    The mortality of patients that might happen after surgery

    Time frame: Within 1 month after surgery

07

Study locations

1 site
  • Qendra Klinike Universitare e Kosoves
    Pristina, Kosovo
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03849014
Lead sponsor
Kushtrim Grezda
Collaborators
University Clinical Centre of Kosova
Responsible party
Kushtrim Grezda (Principal Investigator, Clinical Research, University Clinical Centre of Kosova) — Sponsor-investigator
First posted
Feb 21, 2019
Start date
Jan 1, 2019
Primary completion
Dec 1, 2019
Completion
Jun 1, 2020
Last update
Apr 27, 2021

Study contacts

Kushtrim Grezda, MD
principal investigator · University Clinical Centre of Kosova

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion